PMID: 15229053Jul 2, 2004Paper

Smoking-induced ventral striatum dopamine release

The American Journal of Psychiatry
Arthur L BrodyMark A Mandelkern

Abstract

Substantial evidence from animal models demonstrates that dopamine release in the ventral striatum underlies the reinforcing properties of nicotine. The authors used [(11)C]raclopride bolus-plus-continuous-infusion positron emission tomography (PET) to determine smoking-induced ventral striatum dopamine release in humans. Twenty nicotine-dependent smokers (who smoked > or =15 cigarettes/day) underwent a [(11)C]raclopride bolus-plus-continuous-infusion PET session. During the session, subjects had a 10-minute break outside the PET apparatus during which 10 subjects smoked a cigarette and 10 did not smoke (as a control condition). The group that smoked had greater reductions in [(11)C]raclopride binding potential in ventral striatum regions of interest than the group that did not smoke, particularly in the left ventral caudate/nucleus accumbens and left ventral putamen (range for smoking group=-25.9% to -36.6% reduction). Significant correlations were found between change from before to after the smoking break in craving ratings and change from before to after the break in binding potential for these two regions. Nicotine-dependent subjects who smoked during a break in PET scanning had greater reductions in [(11)C]raclopride bind...Continue Reading

Associated Clinical Trials

Citations

Dec 20, 2005·Psychopharmacology·Jed E Rose
Oct 20, 2011·European Journal of Nuclear Medicine and Molecular Imaging·Karmen K YoderChristine M Herring
Sep 27, 2012·European Archives of Psychiatry and Clinical Neuroscience·Birgit LernbassBirgit Abler
May 8, 2013·Brain Imaging and Behavior·Daniel S AlbrechtKarmen K Yoder
Aug 14, 2008·The British Journal of Psychiatry : the Journal of Mental Science·Mark R C DaglishDavid J Nutt
Aug 11, 2012·The British Journal of Psychiatry : the Journal of Mental Science·Rajeev KrishnadasRobin G McCreadie
Apr 27, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jody TanabeRobert Freedman
May 22, 2007·Science & Practice Perspectives·Joanna S FowlerLinda Chang
Jun 20, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Arthur L BrodyEdythe D London
Feb 13, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Darlene H BrunzellMarina R Picciotto
Oct 13, 2009·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Yantao ZuoJodi I Huggenvik
Jan 8, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Karine Guillem, Laura L Peoples
Feb 19, 2011·Psychopharmacology·Jody TanabeJason R Tregellas
Mar 6, 2007·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Sarah C Christine Lidstone, A Jon Stoessl
Mar 6, 2012·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Janet Audrain-McGovernJoseph Sass
Apr 12, 2012·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Edward F DominoJon-Kar Zubieta
Apr 12, 2012·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Darlene H Brunzell
Dec 1, 2011·Current Cardiovascular Risk Reports·Hedy Kober, Cameron M Deleone
Aug 30, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Matthijs G BossongRené S Kahn
Aug 21, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Bernard Le FollIsabelle Boileau
Jan 12, 2016·Pharmacology, Biochemistry, and Behavior·Julia K BrynildsenElliot A Stein
Jan 25, 2016·Biological Psychiatry·Lena RademacherIngo Vernaleken
Jan 26, 2016·Biological Psychiatry·Mary FalconeCaryn Lerman
Mar 27, 2013·La Presse médicale·Laurent KarilaMichel Reynaud
Mar 3, 2012·Psychiatry Research·Joanne VoiseyCharles Phillip Morris
Dec 30, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Nienke C VulinkDamiaan Denys
Jan 12, 2010·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Hendrika H van HellNick F Ramsey
Aug 12, 2009·Neuroscience and Biobehavioral Reviews·Peter DomeZoltan Rihmer
Jul 5, 2008·Behavioural Brain Research·Riju RayCaryn Lerman
Jul 12, 2008·Neuropharmacology·N D VolkowF Telang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.